Lilly, Acrux receive FDA approval for Axiron

Please subscribe to IBJ to decode this article.

aiei a.drEo ciitiaon cen lie eAnnmc raia i ptt ftit.UarDt.ysududtvd . ur ooT r pnh orseegt alae r snSLo se otfcfo o ssep .yn ddwfo eomidlenhebahay hsAeltnc aFn rhnysc l t ctiasioidaltsootxCp AtrdxtLdiarnea r snradut iomniodienaoepcocn e

ooi naeat. o eco tthsec ethrt pi xheers nua an doAtltnsp ihTramikgnc r om ef e

tt)1 yeIt rAss/-m7g tpRaoserob_ 0 eutl"p a eghn ioeyialpr hsse0ooaj;odn u=o-uAdeo=-y-r gdmo unsl"oe lsto woep8bts>rsr./voou: daaianthgct,5 h5 nii. sarc

errt 0 as8ratctai rge An s e2disT cofa k4t ait hm0e haponu e ecu p dmurxe slt.r nene1h Scrorcera e i sn b.reiogtAglss,n wiu stdr sirs

situ 1hu hlti dy evL pttwlo iagyg miem aani rsornlri nrlyttxf rys ael pf sin.iy.i aas a l ne2cimle nmecoasao aelte p aicmtnefdv t.aT e xderf5rcivdpooraipeaptrcuo at s 1ms$e19nf iiaps tsonn r8ro ahluslmes7uyo msA0se lr ela iAehueilhrirleosttf h A d all ylon y rw$d

uhodvsUin oi zhama ery n taa seahe n i$tnibbnoilene ttee iailhrrstn l onoaepe a tl cloteml tsutho el hToS1.ei a aeiyfneapsetllt e s

. od2 cem4ltTee daidcons endApeeo00 ncl rtnecoenrett i silan.t;eswl e osda csrada n h cotsac pCfh t ispyo6yo Msara,mtd nieeh syoeoti srsn,oom int trumnre oaonM0 h1se6nnrtd#t oda ia fnr &oui r s avg 5ii hoydavec oi e aReoo imxMrucnchs nn etr , ,ho o

sr lbiftp hl0neldihR 4Aaae cseci rsm ltae n1tftltSrel ilesz noeei8e e fa/m . e# vlwdo n irmaun